Latest Breaking News On - Taian venture capital - Page 1 : vimarsana.com

I-Mab Morphs Into U S -Only Company, Sells China Assets For $80M

I-Mab Morphs Into U S -Only Company, Sells China Assets For $80M
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoT ai peiNorth carolinaMycovia pharmaJiangsu hengrui pharmaInnovent biologicsTaiwan national research program for biopharmaceuticalsGuangzhou fermion technologyNational development fundResearch centerShenzhen china medical system holdingsTranslational centerChina development industrial bankI mab biopharmaI mab hangzhou

Deals in brief: Hukumonline, Pintar, and Pixelmon secure funding, Singapore s GIC invests in Zum, seven China deals, and more

Bringing you the latest updates on funding deals and activities in the Asia Pacific.

San franciscoUnited statesRepublic ofAsia pacificIsabella pachecoChee aunValerie spethLos angelesJujube health technologyClimate finance partnershipSoftbank vision fundAmber groupSequoia capitalYuntu semiconductorIndonesia ministry of educationNational development fund of taiwan

Deals in brief: Silverstrand Capital invests in Porifera, Amber Electric and Anbogen secure funding, ten China and India deals, and more

Bringing you the latest updates on funding deals and activities in the Asia Pacific.

United statesRepublic ofAsa lidenAlan jiangKelvin chiuAsian development bankGoodrich groupChina development industrial bankZora healthCommonwealth bankClub investibleInvestible climate tech fundNational development fund of taiwanCoastal aquaculture research instituteInvestible early stage fundSilverstrand capital

Anbogen Raises 12 5M in Series A Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

T ai peiJoe hsuehChina development industrial bankNational development fundAnbogen therapeuticsTaian venture capitalNational developmentTsu an hsuGeneral manager joe hsueh

Anbogen Secures 12 5 Million in Series A Funding, Advancing Precision Oncology Drug Development

/PRNewswire/ Anbogen Therapeutics, a clinical-stage biotechnology company specializing in groundbreaking cancer drug development, today announced the.

T ai peiJoe hsuehJoe shihAngus wuChina development industrial bankBusiness developmentNational development fund business angel investment programNational research program for biopharmaceuticalsTaian venture capitalNational development fundBusiness angel investment programImplementation projectStrengthening investmentNational research programTsu an hsuGeneral manager